Fig. 2

a Distribution of calretinin in plasma of mesothelioma patients and asbestos-exposed controls. b Distribution of mesothelin in plasma of mesothelioma patients and asbestos-exposed controls. c Receiver operating characteristics (ROC) curves of calretinin, mesothelin, and sequential combination of calretinin and mesothelin